10-Q
Quarterly Report
Autonomix Medical, Inc.
AMIX
NASDAQ
CIK: 1617867
File #: 001-41940
Balance Sheet
24 line items · 2 periods
XBRL
| Item | Jun 30, 2025 | Mar 31, 2025 |
|---|---|---|
Current assets: | ||
Cash and cash equivalents | 8,589,000 | 9,136,000 |
Other current assets | 389,000 | 473,000 |
Total current assets | 8,978,000 | 9,609,000 |
Long term assets: | ||
Fixed assets, net | 19,000 | 21,000 |
Deferred offering costs | 0 | 176,000 |
Total long term assets | 19,000 | 197,000 |
Total Assets | 8,997,000 | 9,806,000 |
Current liabilities: | ||
Accounts payable | 815,000 | 676,000 |
Accrued expenses | 1,150,000 | 1,031,000 |
Total current liabilities | 1,965,000 | 1,707,000 |
Total Liabilities | 1,965,000 | 1,707,000 |
Stockholders' equity: | ||
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2025 and March 31, 2025, respectively | 0 | 0 |
Common stock, $0.001 par value, 500,000,000 shares authorized, 4,022,625 and 2,497,033 shares issued and outstanding as of June 30, 2025 and March 31, 2025, respectively | 4,000 | 2,000 |
Additional paid-in capital | 60,744,000 | 58,476,000 |
Accumulated deficit | (53,716,000) | (50,379,000) |
Total Stockholders' Equity | 7,032,000 | 8,099,000 |
Common Stock | 4,000 | 2,000 |
Additional Paid-in Capital | 60,744,000 | 58,476,000 |
Retained Earnings | (53,716,000) | (50,379,000) |
Total Liabilities and Stockholders' Equity | 8,997,000 | 9,806,000 |